• About Us
  • Advertise
  • Contact Us
  • DMCA
  • Privacy Policy
  • Follow on Google News
Sunday, October 1, 2023
  • Login
News Punjab
  • Home
  • Punjab
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Tech
    • App News
  • Auto
  • Sports
  • Finance/Money
  • Others
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
  • Home
  • Punjab
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Tech
    • App News
  • Auto
  • Sports
  • Finance/Money
  • Others
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
News Punjab
No Result
View All Result
Home Lifestyle Health & Fitness

Synthesis of agonist molecule by CSIR-IICT for COVAXIN

by News Punjab Desk
March 1, 2021
in Health & Fitness
Reading Time: 2 mins read
A A
0
Share on FacebookShare on Twitter

New Delhi: Council of Scientific & Industrial Research (CSIR)’s constituent laboratories have been working relentlessly in partnership with industry to launch repurposed drugs through process development and conducting clinical trials. CSIR labs have also extensively contributed towards the launching of diagnostic kits including Feluda and Dry Swab Direct RT-PCR method for the screening of SARS-CoV-2.

The indigenous vaccine for COVID-19, COVAXIN,developed by Hyderabad based Bharat Biotech, is a highly purified, whole virion, inactivated SARS-CoV2. The vaccine is formulated with Algel-IMDG, which contains chemisorbed TLR7/8 agonist onto aluminium hydroxide gel to generate the requisite type of immune responses. Owing to the significant role played by TLR7/8 agonist molecule in the performance of a vaccine, CSIR constituent lab, Indian Institute of Chemical Technology (IICT) based in Hyderabad, was approached by BBIL to develop the synthetic route for the agonist molecule with indigenous chemicals at an affordable price and with the highest purity. This agonist molecule has aided Bharat Biotech to scale up the production of the adjuvant.

RELATED POSTS

Narayana Health launches their First Ever Brand Campaign ‘Take Care’

Narayana Health launches their First Ever Brand Campaign ‘Take Care’

September 30, 2023
KareXpert achieves Ayushman Bharat Digital Mission Certification, paving the way for the digital healthcare revolution

KareXpert achieves Ayushman Bharat Digital Mission Certification, paving the way for the digital healthcare revolution

September 13, 2023

The project was spearheaded by Dr. Chandrasekhar, Director, and Dr. Raji Reddy, Senior Scientist from IICT and has been completed in a record time of 4 months. Also, CSIR-IICT team lead by Dr Mohana Krishna Mudiam, Senior Principal Scientist and Professor Academy of Scientific and Innovative Research (AcCSIR) played a key role in the development of an analytical method for testing TLR7/8 agonist molecule and its method validation procedures through National Accreditation Board for Testing and Calibration Laboratories (NABL) accredited lab.

Acknowledging the work undertaken by CSIR-IICT towards the development of the novel agonist, Dr. Krishna Ella, Chairman and Managing Director of Bharat Biotech said, “The process technology developed by CSIR-IICT for the agonist molecule is playing an important role in the production of adjuvant for COVAXIN.” Dr Shekhar Mande, DG, CSIR and Secretary, DSIR complimented the CSIR-IICT team for rising to the occasion in making the process affordable and enabling the development of agonist molecules in record time and mentioned that this is yet another instance of CSIRs commitment towards ‘Aatmanirbhar Bharat”. (India Science Wire)

Tags: Clinical TrialsCOVID-19CSIRDiagnostic kitsDirect RT-PCRDry SwabFeludaHealthcarepandemicRepurposed DrugsSARS-CoV-2
ShareTweetShareSendSharePinSend
Previous Post

AustralaSian COVID-19 Trial opens in India

Next Post

Sublethal exposure study of lead (Pb) on black clams to provide early warning information on marine pollution

News Punjab Desk

News Punjab Desk

Related Posts

Narayana Health launches their First Ever Brand Campaign ‘Take Care’

Narayana Health launches their First Ever Brand Campaign ‘Take Care’

by News Punjab Desk
September 30, 2023
0

Narayana Health Group – one of India’s leading healthcare providers, committed to delivering exceptional patient care is thrilled to announce...

KareXpert achieves Ayushman Bharat Digital Mission Certification, paving the way for the digital healthcare revolution

KareXpert achieves Ayushman Bharat Digital Mission Certification, paving the way for the digital healthcare revolution

by News Punjab Desk
September 13, 2023
0

This milestone achievement positions KareXpert as a driving force behind the "Digital Healthcare Revolution" sweeping across the nation KareXpert, Jio-backed...

“Empowering Women Through Innovative Healthcare: Dr. Monika Agarwal, Leading Cosmetic Gynaecologist and Laparoscopic Surgeon in Ghaziabad”

“Empowering Women Through Innovative Healthcare: Dr. Monika Agarwal, Leading Cosmetic Gynaecologist and Laparoscopic Surgeon in Ghaziabad”

by News Punjab Desk
September 4, 2023
0

Dr. Monika Agarwal is a renowned gynaecologist and laparoscopic surgeon with extensive experience in laparoscopic surgeries, high-risk pregnancy and cosmetic...

Use of Artificial Intelligence (AI) in Angioplasty, Dr. Ankur Phatarpekar announces the integration of the latest OCT

Use of Artificial Intelligence (AI) in Angioplasty, Dr. Ankur Phatarpekar announces the integration of the latest OCT

by News Punjab Desk
July 26, 2023
0

Mumbai (Maharashtra) : Dr. Ankur Phatarpekar, Interventional Cardiologist and Director at Symbiosis Speciality Hospital Mumbai, announced the integration of the...

Kosmoderma continues to be the big player in the skincare industry with its new and innovative launch

Kosmoderma continues to be the big player in the skincare industry with its new and innovative launch

by News Punjab Desk
July 21, 2023
0

India welcomes its first Regenerative Medicine with Kosmoderma Bangalore (Karnataka) : Kosmoderma recently launched its new technological innovation with Regenerative...

Next Post

Sublethal exposure study of lead (Pb) on black clams to provide early warning information on marine pollution

“Data and Artificial Intelligence are growing sectors among new job clusters”

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Hidden gems from tier 1 and 2 colleges steal spotlight in Contentstack Techsurf 2023

Hidden gems from tier 1 and 2 colleges steal spotlight in Contentstack Techsurf 2023

September 30, 2023
Narayana Health launches their First Ever Brand Campaign ‘Take Care’

Narayana Health launches their First Ever Brand Campaign ‘Take Care’

September 30, 2023
The Circle: Founders Club launches Market Access focused Accelerator Program for 10 Korean startups in India

The Circle: Founders Club launches Market Access focused Accelerator Program for 10 Korean startups in India

September 29, 2023

Categories

  • Agriculture
  • App News
  • Astrology
  • Auto
  • Business
  • Education
  • Entertainment
  • Fashion & Beauty
  • Finance/Money
  • Food
  • Health & Fitness
  • India
  • Lifestyle
  • National
  • Photography
  • Politics
  • Press Release
  • Punjab
  • Religion
  • Science
  • Social Work
  • Sports
  • State News
  • Tech
  • Travel
  • World
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Privacy Policy
  • Follow on Google News

© 2022 News Punjab

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

© 2022 News Punjab

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In